Nivolumab combined with induction chemotherapy and radiotherapy in nasopharyngeal carcinoma: A multicenter phase 2 PLATINUM trial
Jun Ma(Shanghai Institute of Technology), Liangfang Shen(Central South University), Changjuan Tao(Zhejiang Cancer Hospital), Xinqiong Huang(Central South University), Xiaozhong Chen(Tokyo Institute of Technology), Liping Qi(Sun Yat-sen University), Aihua Lin(Guangzhou University of Chinese Medicine), Chen Liu(Beijing Normal University), Shubin Hong(Sun Yat-sen University), Ying Sun(Key Laboratory of Guangdong Province), Shaojun Lin(Fujian Medical University), Feng Jin(China Medical University), Jing Huang(Sun Yat-sen University), Kun-Yu Yang(Wuhan Union Hospital), Desheng Hu(Hubei Cancer Hospital), Yuan Wu(Jiangsu Cancer Hospital), Gang Peng(Suizhou Central Hospital), Yinglin Peng(Sun Yat-sen University), Ling Tang(China University of Petroleum, Beijing), Hui-Ling Huang(Sun Yat-sen University), Wen-Fei Li(Sun Yat-sen University), Guan-Qun Zhou(Sun Yat-sen University), Hongyun Zhao(Sun Yat-sen University), Ji-Bin Li(Sun Yat-sen University)
Cited by 36
Related Papers
Association of Blood Glucose Control and Outcomes in Patients with COVID-19 and Pre-existing Type 2 Diabetes
|Cell Metabolism|2020|1.7k
Gemcitabine and Cisplatin Induction Chemotherapy in Nasopharyngeal Carcinoma
|New England Journal of Medicine|2019|934
A Metagenomic Approach to Characterization of the Vaginal Microbiome Signature in Pregnancy
|PLoS ONE|2012|703